Critical Digestion
Natural health product licensed in Canada
- Licence holder
- Enzymedica Inc.
- NPN or DIN-HM
- 80090319
- Status
- Active licence
- Licence date
- 25 January 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 10 mg | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Aspergillus niger - En entier | 9 mg | Not calculated |
| Lactobacillus casei Source : Cellule entière | 27 Millions d'UFC | Not calculated |
| Lactobacillus casei Source : LC-11 | 27 Millions d'UFC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 2.516 Unités de protéase bactérienne du FCC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 8 mg | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 27 Millions d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : LR-32 | 27 Millions d'UFC | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - en entier | 535 Unités de sumner du FCC | Not calculated |
| alpha-D-Glucoside glucohydrolase Source : Aspergillus niger - En entier | 200 Unités de degrés de pouvoir diastatique du FCC | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger - En entier | 50 FCC HCU | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger - En entier | 1 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier | 1,000 Unités d'activité du xylanase | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier | 7 mg | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 25 FCC BGU | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 8 mg | Not calculated |
| alpha-D-Glucoside glucohydrolase Source : Aspergillus niger - En entier | 5 mg | Not calculated |
Non-medicinal ingredients
Dextrine, Eau purifiée, NA, Citrate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Source of probiotics. Alpha-Galactosidase helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains). Protease is a digestive aid. Protease helps digest proteins. Alpha-galactosidase helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Digestive enzymes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product. This product has come into contact with soy. If you have a soy allergy, do not use this product.
- Effets indésirables connus
Headaches, heartburn, and hypersensitivity/allergy has been known to occur; in which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood pressure medication. Discontinue use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhoea) occur, worsen, or persist beyond 3 days. If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/ blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use. If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80090319
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.